Michael D. Rhine, Executive Vice President and Chief Operating Officer of Onsite Health and Telemedicine at Concentra Group Holdings Parent, Inc., reported the acquisition of 43,883 shares of restricted common stock on November 3, 2026, in a filing submitted to the SEC on November 5, 2026.

Key Highlights

  • Reporting person: Michael D. Rhine, Executive Vice President, Chief Operating Officer Onsite Health and Telemedicine at Concentra Group Holdings Parent, Inc. (NYSE:CON)
  • Transaction date: November 3, 2026, with 43,883 shares of Common Stock acquired at a price of $0
  • Transaction code: A, reflecting an award of restricted stock, not an open-market purchase
  • Vesting schedule: The restricted stock will vest in equal annual installments over four years, according to the filing
  • Post-transaction ownership: Rhine beneficially owned 120,046 shares of Common Stock directly following the reported transaction

Rhine's Restricted Stock Award at Concentra Group Holdings

Concentra Group Holdings Parent, Inc., listed on the New York Stock Exchange under the ticker CON, reported a change in beneficial ownership involving Michael D. Rhine, the company's Executive Vice President and Chief Operating Officer for Onsite Health and Telemedicine. The filing was signed by Timothy F. Ryan as attorney-in-fact on November 5, 2026, and covers a transaction dated November 3, 2026.

According to the filing, Rhine received a grant of 43,883 shares of Common Stock classified under transaction code "A," reflecting an acquisition at a stated price of $0. The filing's explanation of responses notes that this is "a grant of restricted stock which will vest in equal annual installments over four years." No derivative securities were reported in connection with this transaction. Rhine's address of record is listed as c/o Concentra Group Holdings Parent, Inc., 5080 Spectrum Drive, Suite 1200W, Addison, Texas 75001.

Following the reported transaction, Rhine's direct beneficial ownership in Concentra Common Stock stood at 120,046 shares, as stated in Table I of the filing. The filing was submitted by one reporting person and was not indicated as an amendment to a prior filing. No Rule 10b5-1 plan was indicated in connection with this award.

What Was Disclosed

The filing reported that Michael D. Rhine acquired 43,883 shares of Concentra Common Stock on November 3, 2026, through a restricted stock grant vesting over four years, bringing his total direct beneficial ownership to 120,046 shares.